RATIONALE: Patients sensitized to nsLTP comprise a heterogeneous group in terms of sensitization profile, symptom severity and complexity in diagnosis. The aim of this study is to compare sensitivity, specificity, positive and negative values (PPV and NPP) of skin prick test (SPT) and specific IgE (sIgE) in the diagnosis of peanut allergy in patients with LTPSyndrome.
Department of Pediatrics, MedStar Georgetown University Hospital, Washington, DC, 2 Allergy Associates of Northern VA, Arlington, VA. RATIONALE: The Learning Early about Peanut Allergy (LEAP) trial demonstrated that early introduction of peanut products in high risk infants decreases the risk of peanut allergy by 5 years of age. High risk patients were defined as infants with severe eczema, and or egg allergy. In our study, we aimed to identify other high risk factors associated with the development of peanut allergy and thereby additional patient populations who may benefit from early introduction of peanut products. METHODS: A retrospective chart review was performed on 103 patients ages 0-3 years old with either positive (> _3mm) skin test to peanuts or serum peanut immunoglobulin E (IgE) level greater than or equal to 1.0 kU/L. Clinical data from this subset of patients was analyzed for additional risk factors (i.e. other food allergies, family history of food allergy, parental asthma, etc.) that could lead to the development of peanut allergy using logistic regression analysis. RESULTS: Parental asthma was found to be significantly associated with an increased risk of peanut allergy in the child (p50.0359, OR 2.743).
Other concurrent food allergy to soy was also associated with a propensity for peanut allergy (p-value 0.0150, OR 6.344). CONCLUSIONS: Patients with food allergy to soy or parental asthma should be further investigated as potential identifiers of patients at high risk of developing a peanut allergy.
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Pru p3 sublingual immunotherapy and allergy to lipid transfer protein, a case report Macarena Piñero-Saavedra, MD, M, Isabel Gonzalez-Martin, MD, Marta Rodriguez-Lantaron, MD, Belen Hinojosa-Jara, MD, and Marina Lluncor, MD; Allergy Department, Juan Ramon Jimenez Hospital, Huelva, Spain. RATIONALE: Pru p3 belongs to the lipid transfer protein (LTP) panallergen family. LTPs are related with severe anaphylactic reactions after its ingestion. Pru p3 sublingual immunotherapy (Pru p3 SLIT) can increase allergen tolerance. METHODS: Skin prick test (SPT) and serum specific IgE to Pru p3 (peach), peanut, nut, onion, tomato, Artemisia pollen. Oral food challenge to onion and tomato (raw and cooked). RESULTS: we present a 54 y.o. women with a history of anaphylactic reactions with several foods (rosaceae fruit, nuts, tomato, onion and lettuce), including cross-contamination (fried food). She was on a very restricted diet with high impact on quality life. SPT were all positive, confirming the sensitization. Serum specific IgE were peach (Pru p 3; LTP) 3.47 UIa/mL, peanut 3.35 UIa/mL, nut 1.09 UIa/mL, onion 0.42 UIa/mL, tomato 1.73 UIa/mL, Artemisia pollen 5.50 UIa/mL. Risk and benefits were reviewed and discussed with patient and Pru p3 SLIT was started following standard recommendations and 4 days rush schedule. An excellent tolerance both, in the build-up and maintenance phases, was observed. After 6 months, upon request of the patient, oral food challenges to onion and tomato (raw and cooked) were carried out without reactions. She added both foods, widely used in Mediterranean diet, to her daily diet with good tolerance. CONCLUSIONS: In this case, we evaluate the efficacy of Pru p3 SLIT in a 6-month period. Pru p3 SLIT can reduce accidental intake risk and improve quality of patient's life.
